✦ LIBER ✦

Prolonged Double Antiplatelet Therapy in a Cohort of “De Novo” Diabetic Patients Treated With Drug-Eluting Stent Implantation

✍ Scribed by Nadia Mollichelli; Nuccia Morici; Federico Ambrogi; Azeem Latib; Patrizia Boracchi; Cosmo Godino; Luca Ferri; Alfonso Ielasi; Alaide Chieffo; Matteo Montorfano; Antonio Colombo

Book ID: 113447006
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 371 KB
Volume: 105
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2009.12.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug-Eluting Stenting Followed by Cilost

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)

✍ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Drug-Eluting Stenting Followed by Cilost

✍ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Double Antiplatelet Therapy After Drug-E

Double Antiplatelet Therapy After Drug-Eluting Stent Implantation: Risk Associated With Discontinuation Within the First Year

✍ Ignacio Ferreira-González; Josep R. Marsal; Aida Ribera; Gaietà Permanyer-Mirald 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 635 KB

TCT-156: “Safety of Dual Antiplatelet Th

TCT-156: “Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Drug-eluting stent thrombosis after cilo

Drug-eluting stent thrombosis after cilostazol withdrawal in a patient previously treated with triple antiplatelet therapy

✍ Eui Im; Sang-Hak Lee; Jung-Sun Kim; Donghoon Choi; Yangsoo Jang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Discontinuation of antiplatelet therapy

Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study

✍ Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND Drug‐eluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to platelet‐mediated thrombosis. Given the anecdotal evidence and case series sugges